Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment
Top Cited Papers
- 28 February 2009
- journal article
- Published by Elsevier BV in Regulatory Toxicology and Pharmacology
- Vol. 53 (1), 39-45
- https://doi.org/10.1016/j.yrtph.2008.10.006
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Human health risk assessments for three neuropharmaceutical compounds in surface watersRegulatory Toxicology and Pharmacology, 2008
- Potential ecological and human health risks associated with the presence of pharmaceutically active compounds in the aquatic environment.Critical Reviews in Toxicology, 2004
- Screening Analysis of Human Pharmaceutical Compounds in U.S. Surface WatersEnvironmental Science & Technology, 2003
- From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areasWater Science & Technology, 2002
- Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research dataToxicology Letters, 2002
- The use of measured boron concentration data from the GREAT-ER UK validation study (1996–1998) to generate predicted regional boron concentrationsScience of The Total Environment, 2000
- Pharmaceuticals in the Environment—A Human Risk?Regulatory Toxicology and Pharmacology, 1998
- Occurrence, fate and effects of pharmaceutical substances in the environment- A reviewChemosphere, 1998
- Development of a geography-referenced regional exposure assessment tool for European rivers - great-er contribution to great-er #1Chemosphere, 1997
- An improved model for predicting the fate of consumer product chemicals in wastewater treatment plantsWater Research, 1993